Tailoring Therapy in Older Adults With Hematologic Malignancies

Area of Science:

• Geriatric Medicine
• Hematology
• Oncology

Background:

• Hematologic malignancies predominantly affect older adults.
• Many elderly patients have unique needs regarding chemotherapy tolerance and supportive care.
• Geriatric assessment (GA) offers a framework to address these needs in cancer care.

Purpose of the Study:

• To review the evidence supporting the use of GA in older adults with hematologic malignancies.
• To explore how GA can optimize treatment selection, supportive care, and outcomes.
• To discuss future directions for integrating GA in hematologic oncology.

Main Methods:

• Review of existing literature and data on GA in older adults with blood cancers.
• Analysis of GA's role in treatment planning, hematopoietic cell transplantation (HCT), and advanced therapies like CAR-T.
• Exploration of GA's application in both community and academic settings.

Main Results:

• GA guides treatment selection, dose adjustments, and supportive care for older adults with blood cancers.
• GA aids in identifying suitable candidates for HCT and personalizing pre- and post-transplant management.
• GA improves risk stratification for toxicities in therapies like CAR-T for relapsed lymphoma and multiple myeloma.

Conclusions:

• Geriatric assessment is a valuable tool for enhancing the care of older adults with hematologic malignancies.
• Integrating GA across different treatment modalities, including HCT and CAR-T, can improve patient outcomes.
• Further research is needed to optimize the application of GA in hematologic oncology.